Neuropathology of Rett syndrome - PubMed (original) (raw)

Neuropathology of Rett syndrome

K Jellinger et al. Acta Neuropathol. 1988.

Abstract

Rett syndrome is an increasingly recognized progressive disorder in females, commencing in infancy and characterized by autistic behavior, gait ataxia, stereotyped movements, seizures and generalized growth and mental retardation, possibly associated with disorders of central biogenic amine synthesis. The gene locus and pathogenesis of Rett syndrome are unknown. Autopsy studies in nine girls dying between 4 and 17 years, and sural nerve and muscle biopsies from two girls aged 3 and 17 years showed: (1) diffuse cortical atrophy/micrencephaly, with a decrease in brain weight by 12% to 34% of age-matched controls, apparently related to the duration of the disorder; (2) mild diffuse cortical atrophy with increased amounts of neuronal lipofuscin and occasional mild gliosis, but without signs of a storage disorder; (3) underpigmentation of the zona compacta nigrae, which showed fewer well-pigmented neurons for age and fewer melanin granules per neuron, while total numbers of nigral neurons and the substructure of neuromelanin were normal for age. No pathological changes were seen in other transmitter-specific brain stem nuclei; (4) immunoreactivity for tyrosine hydroxylase was slightly reduced in nigral and hypothalamic neurons, and the pituitary gland showed decreased immunoreaction for prolactin and growth hormone; (5) ultrastructurally, in frontal cortex and caudate nucleus, isolated abnormal neurites and reactive or degenerative axonal swellings were seen; the latter are possibly related to the nigral changes, suggesting some dysfunction of the dopaminergic nigrostriatal system, which is supported by neurochemical data; (6) preliminary biochemical studies revealed increased beta-endorphines in thalamus and cerebellum; (7) peripheral nerves demonstrated increase in small fibers without demyelination and increased numbers of neurofilaments in axons, suggesting distal axonopathy, while skeletal muscle showed alterations in the sarcoplasmic reticulum with circular profiles in the Z-filaments. These nonspecific changes may be interpreted as early signs of denervation. The variety of lesions in the central, neuroendocrine and peripheral neuromuscular systems in Rett syndrome are discussed with regard to their clinical and biochemical significance.

PubMed Disclaimer

Similar articles

• Neuropathology of Rett syndrome.
  Jellinger K, Seitelberger F. Jellinger K, et al. Am J Med Genet Suppl. 1986;1:259-88. doi: 10.1002/ajmg.1320250528. Am J Med Genet Suppl. 1986. PMID: 3087188
• Peripheral nerve involvement in the Rett syndrome.
  Jellinger K, Grisold W, Armstrong D, Rett A. Jellinger K, et al. Brain Dev. 1990;12(1):109-14. doi: 10.1016/s0387-7604(12)80189-6. Brain Dev. 1990. PMID: 2344004
• Peripheral nerve findings in Rett syndrome.
  Haas RH, Love S. Haas RH, et al. J Child Neurol. 1988;3 Suppl:S25-30. doi: 10.1177/0883073888003001s06. J Child Neurol. 1988. PMID: 2848881
• Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers.
  Mancardi GL, Di Rocco M, Schenone A, Veneselli E, Doria M, Abbruzzese M, Tabaton M, Borrone C. Mancardi GL, et al. J Neurol Sci. 1992 Jul;110(1-2):121-30. doi: 10.1016/0022-510x(92)90018-g. J Neurol Sci. 1992. PMID: 1506851 Review.
• Discussant--pathophysiologies of Rett syndrome.
  Segawa M. Segawa M. Brain Dev. 2001 Dec;23 Suppl 1:S218-23. doi: 10.1016/s0387-7604(01)00372-2. Brain Dev. 2001. PMID: 11738876 Review.

Cited by

• Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
  Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E, Matsuishi T. Okabe Y, et al. PLoS One. 2012;7(4):e35354. doi: 10.1371/journal.pone.0035354. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22532851 Free PMC article.
• Progress in Rett Syndrome: from discovery to clinical trials.
  Percy AK. Percy AK. Wien Med Wochenschr. 2016 Sep;166(11-12):325-32. doi: 10.1007/s10354-016-0491-9. Epub 2016 Aug 4. Wien Med Wochenschr. 2016. PMID: 27491553 Free PMC article.
• Experimental models of Rett syndrome based on Mecp2 dysfunction.
  Calfa G, Percy AK, Pozzo-Miller L. Calfa G, et al. Exp Biol Med (Maywood). 2011 Jan;236(1):3-19. doi: 10.1258/ebm.2010.010261. Exp Biol Med (Maywood). 2011. PMID: 21239731 Free PMC article. Review.
• Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.
  Pappas SS, Leventhal DK, Albin RL, Dauer WT. Pappas SS, et al. Curr Top Dev Biol. 2014;109:97-169. doi: 10.1016/B978-0-12-397920-9.00001-9. Curr Top Dev Biol. 2014. PMID: 24947237 Free PMC article. Review.
• Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor.
  Szczesna K, de la Caridad O, Petazzi P, Soler M, Roa L, Saez MA, Fourcade S, Pujol A, Artuch-Iriberri R, Molero-Luis M, Vidal A, Huertas D, Esteller M. Szczesna K, et al. Neuropsychopharmacology. 2014 Nov;39(12):2846-56. doi: 10.1038/npp.2014.136. Epub 2014 Jun 11. Neuropsychopharmacology. 2014. PMID: 24917201 Free PMC article.

References

1. 1. Acta Neuropathol. 1976 Dec 21;36(4):347-62 - PubMed
2. 1. Neurosci Biobehav Rev. 1986 Fall;10(3):317-38 - PubMed
3. 1. Neurology. 1978 Feb;28(2):139-46 - PubMed
4. 1. Ann Neurol. 1987 Apr;21(4):377-82 - PubMed
5. 1. N Engl J Med. 1985 Oct 10;313(15):921-4 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database